-
18 July 2022
Global Fund Appoints Susanne Kuehn as Ethics Officer and Head of the Ethics Office
-
18 July 2022
Placing Orders and Procuring Health Products for 2023
-
13 July 2022
Global Fund Ranks in Good Category in Leading Transparency Index
-
21 June 2022
The Global Fund Joins Partners in Committing to Address Large Shortfalls in Oxygen
-
17 June 2022A Leap of Pride
-
13 June 2022
Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis
-
20 May 2022
New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP
-
20 May 2022
External Quality Assessment: Highest Possible Results for OIG Audit and Investigation Units
-
10 May 2022Pandemic Preparedness and Response - Thematic Report
-
03 May 2022
Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department
-
29 April 2022Conflicts, Crises and Displaced People: How the Global Fund Works in Challenging Operating Environments - Thematic Report
-
08 April 2022
Opportunity for Evaluation of Diagnostic Products